Yüklüyor......
Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin
BACKGROUND: Cancer relapse and metastasis is an obstacle to the treatment of breast cancer. Breast cancer stem cells (BCSCs), which can evade the killing effect of traditional chemotherapies, such as doxorubicin (DOX), may contribute to cancer development. Therefore, it is necessary to develop novel...
Kaydedildi:
| Yayımlandı: | Int J Nanomedicine |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6717853/ https://ncbi.nlm.nih.gov/pubmed/31695364 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S200482 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|